Data gathered: December 21
Alternative Data for Amphastar P
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 62 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,129 | Sign up | Sign up | Sign up |
| Twitter Mentions | 6 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Amphastar P
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
| Price | $39.14 |
| Target Price | Sign up |
| Volume | 2,200,000 |
| Market Cap | $1.89B |
| Year Range | $36.99 - $53.4 |
| Dividend Yield | 0% |
| PE Ratio | 13.09 |
| Analyst Rating | 75% buy |
| Industry | Biotechnology |
In the news
 |
Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?December 4 - Yahoo |
Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock OptionsDecember 4 - Yahoo |
|
 |
Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?November 30 - Yahoo |
 |
Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare ConferenceNovember 26 - Yahoo |
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceNovember 13 - Finnhub |
|
 |
Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses ExpectationsNovember 7 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 191M | 89M | 102M | 40M | 55M | 0.960 |
| Q2 '24 | 182M | 87M | 95M | 38M | 52M | 0.940 |
| Q1 '24 | 172M | 82M | 90M | 43M | 62M | 1.040 |
| Q4 '23 | 178M | 82M | 96M | 36M | 57M | 0.880 |
| Q3 '23 | 181M | 72M | 108M | 49M | 83M | 1.150 |
Insider Transactions View All
| Zhou Rong filed to sell 118,469 shares at $45.2. December 16 '24 |
| Zhou Rong filed to sell 118,469 shares at $44.4. December 16 '24 |
| PRINS RICHARD K filed to sell 30,471 shares at $43.8. December 11 '24 |
| PRINS RICHARD K filed to sell 31,471 shares at $48.8. November 13 '24 |
| Zhou Rong filed to sell 118,388 shares at $48.9. November 13 '24 |
Similar companies
Read more about Amphastar P (AMPH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Amphastar P?
The Market Cap of Amphastar P is $1.89B.
What is Amphastar P's PE Ratio?
As of today, Amphastar P's PE (Price to Earnings) ratio is 13.09.
What is the current stock price of Amphastar P?
Currently, the price of one share of Amphastar P stock is $39.14.
How can I analyze the AMPH stock price chart for investment decisions?
The AMPH stock price chart above provides a comprehensive visual representation of Amphastar P's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Amphastar P shares. Our platform offers an up-to-date AMPH stock price chart, along with technical data analysis and alternative data insights.
Does AMPH offer dividends to its shareholders?
As of our latest update, Amphastar P (AMPH) does not offer dividends to its shareholders. Investors interested in Amphastar P should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Amphastar P?
Some of the similar stocks of Amphastar P are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.